556
Participants
Start Date
November 1, 2024
Primary Completion Date
March 1, 2029
Study Completion Date
March 1, 2029
Patient survey
To assess patient preferences and barriers for attributes of BE/EAC screening modalities patients will complete a survey evaluating 5 domains: benefit of detection (sensitivity), convenience (time, setting), screening related physical harms (procedural discomfort), and financial harms. Prior to distribution, the survey will be refined and pretested among a sample of 5 patients.
RECRUITING
University of Colorado Anschutz Medical Campus, Aurora
Collaborators (1)
American Society for Gastrointestinal Endoscopy
OTHER
University of California, Los Angeles
OTHER
University of Michigan
OTHER
Exact Sciences Corporation
INDUSTRY
VA Medical Center-West Los Angeles
FED
University of Texas Southwestern Medical Center
OTHER
University of Colorado, Denver
OTHER